Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Uncontrolled Trial to Assess the Non-immunogenicity and Safety of Org 36286 in Patients Undergoing Repeated Controlled Ovarian Stimulation Cycles Using a Multiple Dose GnRH Antagonist Protocol

NCT00696878 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00696878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00696878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Uncontrolled Trial to Assess the Non-immunogenicity and Safety of Org 36286 in Patients Undergoing Repeated Controlled Ovarian Stimulation Cycles Using a Multiple Dose GnRH Antagonist Protocol
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
September 26, 2006
Completion date
May 15, 2009
Enrollment
682 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

in vitro fertilization